Special Issues

Antibodies runs special issues to create collections of papers on specific topics. The aim is to build a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors who are experts in the subject and oversee the editorial process for papers. Papers published in a Special Issue will be collected together on a dedicated page of the journal website. For any inquiries related to a Special Issue, please contact the Editorial Office.

Search by Title/Keyword
Order results
Results per page
Convergence in Neutralizing Antibodies Elicited by Viruses
edited by
submission deadline 30 Sep 2022 | Viewed by 157
Keywords: antibodies; neutralizing antibodies; monoclonal antibodies; B cell receptor; B cell receptor repertoire; viruses; virology; convergent evolution; public clonotypes; public antibodies
Antibody Drug and Target Discovery for Cancer Therapies
edited by
submission deadline 20 Oct 2022 | 2 articles | Viewed by 2437
Keywords: therapeutic targets; intra or extracellular targets; antibody drug conjugates; cancer immunotherapy; bispecific T-cell engager antibodies; intracellular antibodies; target validation; novel inhibitory mechanisms
Engineering (Bispecific) Antibodies for Cancer and Immunotherapy
edited by
submission deadline 20 Oct 2022 | 1 articles | Viewed by 2274
Keywords: engineered antibodies; bispecific antibodies; antibody fusion proteins; immunocytokines; cancer therapy; immunotherapy
Novel Strategies and Technologies for the Development of Tumor-Specific Antibodies
edited by Alexander J. Bankovich
submission deadline 20 Oct 2022 | Viewed by 137
Keywords: hybridoma; antibody discovery; immunizations; display technologies; effector function; monoclonal antibodies; bispecific antibodies
(This special issue belongs to the Section Antibody Discovery and Engineering)
Second Generation Nanobodies and Their Applications
edited by Theo Verrips and Hans de Haard
submission deadline 31 Oct 2022 | Viewed by 133
Keywords: nanobodies; variable domains of heavy chain antibodies (VHH); bivalent; bi-specific and multi-specific VHH; anti-viral agents; intrabodies; affinity ligands and imaging agents; chemical and physical properties of VHH; structural studies of VHH with cognate antigens; including the novel protein folding and interaction tools such as AlphaFold.2 and biophysical methods to verify these data
Computational Discovery of Antibodies
edited by , Ponraj Prabakaran and Abhinandan Raghavan
submission deadline 31 Oct 2022 | 1 articles | Viewed by 1713
Keywords: antibody discovery; antibody engineering; antibody design; antigen– antibody interaction; computational biology; artificial intelligence; machine learning; deep learning; next-generation sequencing; antibiome; antibodyome; immunogenetics; BCR; NGS
Targeting Tumor Cells with Antibodies Enhances Anti-Tumor Immunity
edited by Xiaoyan Qiu
submission deadline 20 Nov 2022 | Viewed by 76
Keywords: anti-tumor antibodies; tumor targets; tumor antigen; tumor immunotherapy; monoclonal antibodies; therapeutic antibodies
(This special issue belongs to the Section Antibody-Based Therapeutics)
The Role of Antibodies in SARS-CoV-2 Infection
edited by Kai Schulze-Forster
submission deadline 30 Nov 2022 | Viewed by 84
Keywords: SARS-CoV-2 antibodies; SARS-CoV-2 vaccines; G protein-coupled receptor autoantibodies; immunoassay; long COVID; virus-like particles
(This special issue belongs to the Section Humoral Immunity)
Monoclonal Antibody-Directed Therapy Series II
edited by and Brooke Rock
submission deadline 20 Dec 2022 | 9 articles | Viewed by 11113
Keywords: monoclonal antibody (mAb) therapies; antibody medicines; antibody drug conjugates (ADCs); bispecific and multispecific antibodies; next-generation biologics; follow-on biologics; single-domain antibodies— nanobodies; optimization of antibody products; formulation of mAbs; biosimilars; biobetters; antibody engineering; antibody pharmacokinetics; antibody distribution in vivo and in vitro; modeling and simulation of antibody clearance; physical– chemical characterization of antibody products; mechanisms influencing antibody clearance 
Redirecting T Cells with Chimeric Antigen Receptor (CAR) for the Treatment of Cancer
edited by Xuyao Zhang and Xin He
submission deadline 31 Dec 2022 | Viewed by 157
Keywords: CAR T cells; Antigen escape; Immunosuppressive tumor microenvironment; Novel tumor target; Genome engineering; Cell therapy technology; Novel strategies
(This special issue belongs to the Section Antibody-Based Therapeutics)
Coronavirus-Targeting Antibodies submission deadline 31 Dec 2022 | 1 articles | Viewed by 607
Keywords: SARS-CoV-2; human coronaviruses; neutralising antibody; binding antibody; Fc mediated immunity; nanobodies
Antibodies: 10th Anniversary
edited by and
submission deadline 31 Dec 2022 | Viewed by 61
Phage and Ribosome Display for Antibody Discovery and Optimization submission deadline 31 Dec 2022 | 1 articles | Viewed by 1684
Keywords: phage and ribosome display; display technologies; recombinant antibody formats; combinatorial libraries; biopanning; selection; lead characterization; humanization and affinity maturation; optimization; physiochemical properties; macromolecular mechanisms and interactions; diagnostics; therapeutics; other applications
Autoimmunity Induced Thrombosis
edited by
submission deadline 20 Jan 2023 | Viewed by 76
(This special issue belongs to the Section Antibody-Based Diagnostics)
Novel Approaches in Discovery and Design of Antibody-Based Therapeutics
edited by Alastair Lawson
submission deadline 20 Jan 2023 | Viewed by 154
Keywords: variable region discovery; antibody engineering; rational design; structure-based design; single chain designs; format engineering; antibody conjugates; new technologies
Higher Order Structure Characterization of Therapeutic Antibodies-Second Volume
edited by Aaron T. Wecksler
submission deadline 10 Feb 2023 | Viewed by 263
Keywords: therapeutic monoclonal antibodies; higher order structure; structure/function relationship; structural comparability
Specific Targeting of Cancer with siRNA, CRISPR Cas and Antibodies
edited by Thomas Böldicke
submission deadline 20 Mar 2023 | Viewed by 32
Keywords: tumor specific targeting; adeno associated virus; nanoparticle; tumor associated antigens; neoantigens; siRNA; CRISPR Cas; intrabodies
(This special issue belongs to the Section Antibody-Based Therapeutics)
Back to TopTop